GeneDx Holdings Corp. (WGS)
65.83
-2.70
(-3.94%)
USD |
NASDAQ |
Oct 08, 11:23
GeneDx Holdings EPS Diluted (Quarterly) : -0.5971 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5971 |
| March 31, 2026 | -2.158 |
| December 31, 2025 | -0.6082 |
| September 30, 2025 | -0.2651 |
| June 30, 2025 | 0.3633 |
| March 31, 2025 | -0.232 |
| December 31, 2024 | 0.1941 |
| September 30, 2024 | -0.3068 |
| June 30, 2024 | -1.096 |
| March 31, 2024 | -0.7766 |
| December 31, 2023 | -0.9921 |
| September 30, 2023 | -1.640 |
| Date | Value |
|---|---|
| June 30, 2023 | -1.838 |
| March 31, 2023 | -3.04 |
| December 31, 2022 | -26.23 |
| September 30, 2022 | -6.724 |
| June 30, 2022 | -8.377 |
| March 31, 2022 | -10.38 |
| December 31, 2021 | -5.491 |
| September 30, 2021 | 5.136 |
| June 30, 2021 | -1383.91 |
| March 31, 2021 | -11511.15 |
| December 31, 2020 | -207470.3 |
| September 30, 2020 | -33.76 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Twist Bioscience Corp. | -0.5617 |
| CS Diagnostics Corp. | 0.0002 |
| Aibotics, Inc. | -0.0008 |
| Intellia Therapeutics, Inc. | -0.7989 |
| 10X Genomics, Inc. | -0.138 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.74M |
| Revenue (Quarterly) | 114.44M |
| Total Expenses (Quarterly) | 132.18M |
| Enterprise Value | 2.077B |
| Gross Profit Margin (Quarterly) | 64.05% |
| Profit Margin (Quarterly) | -15.50% |
| Earnings Yield | -5.51% |
| Normalized Earnings Yield | -3.957 |